Omar Soler-Cedeño
8PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 11, 2025
Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.Omar Soler-Cedeño, Hai-Ying Zhang, Emma Xiong
|Sep 25, 2025
Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice.Hannah Alton, Emily Linz, Guo-Hua Bi
|Apr 10, 2024
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects.Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi
|Mar 28, 2024
Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents.Rui Song, Omar Soler-Cedeño, Zheng-Xiong Xi
|Aug 04, 2023
The parabrachial to central amygdala pathway is critical to injury-induced pain sensitization in mice.Jeitzel M Torres-Rodriguez, Torri D Wilson, Sudhuman Singh
|Oct 27, 2022
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.Omar Soler-Cedeno, Zheng-Xiong Xi
Pageof 2
Frequent Collaborators
5 joint publications
Zheng-Xiong Xi
1 joint publications
Sudhuman Singh
1 joint publications
Spring Valdivia
1 joint publications
Barbara Benowitz
1 joint publications
Sarah Chaudhry
1 joint publications
Jun Ma
1 joint publications
Anisha P Adke
1 joint publications
Mario A Penzo
1 joint publications
Yarimar Carrasquillo
1 joint publications
Jeitzel M Torres-Rodriguez
